TickerFactsScreenerDevelopers

RELMADA THERAPEUTICS, INC. (RLMD) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$2.84M2012: -$3.71M2013: -$17.95M2014: -$1.11M2015: $8.81M2016: $7.04M2017: $1.46M2018: $1.43M2019: $115.68M2020: $105.58M2021: $208.26M2022: $140.44M2023: $85.36M2024: $35.52M2025: $86.51M$86.51M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$86.51M+143.5%
2024$35.52M-58.4%
2023$85.36M-39.2%
2022$140.44M-32.6%
2021$208.26M+97.3%
2020$105.58M-8.7%
2019$115.68M+7963.0%
2018$1.43M-1.8%
2017$1.46M-79.3%
2016$7.04M-20.1%
2015$8.81M+894.4%
2014-$1.11M+93.8%
2013-$17.95M-383.6%
2012-$3.71M-30.7%
2011-$2.84M—